After listening to the presentation I feel that 5.50 today is a real possibility mainly because of 2 take aways.
Firstly, using temcell as a guide they said the Japanese cost of treatment generally represents a 50% discount to what can be charged in the US - i think most models used the same price and multiplied it by an increased patient cohert (the expected sales can now be DOUBLED).
Secondly, confirmation that non-covid ARDS patients are 60,000-70,000 annually. Remember we treat those in life or death situations, so we can assume that we charge a minimum of 100k/ treatment... you do the maths!
After listening to the presentation I feel that 5.50 today is a...
-
- There are more pages in this discussion • 11,170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.38 |
Change
-0.080(5.50%) |
Mkt cap ! $1.569B | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.43 | $1.37 | $5.321M | 3.829M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 12214 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 37660 | 5 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |